2003
Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults
Benin AL, O'Brien KL, Watt JP, Reid R, Zell ER, Katz S, Donaldson C, Parkinson A, Schuchat A, Santosham M, Whitney CG. Effectiveness of the 23-Valent Polysaccharide Vaccine against Invasive Pneumococcal Disease in Navajo Adults. The Journal Of Infectious Diseases 2003, 188: 81-89. PMID: 12825175, DOI: 10.1086/375782.Peer-Reviewed Original ResearchConceptsInvasive pneumococcal diseaseOverall vaccine effectivenessNavajo adultsPneumococcal diseaseCase patientsControl patientsPolysaccharide vaccineVaccine effectivenessGeneral United States populationSerious pneumococcal diseasePneumococcal polysaccharide vaccineCohort methodologyUnited States populationCase-control setsActive surveillanceObservational studyMedical conditionsPatientsMedical careDiseaseAdultsDiabetesRegression analysisVaccineAlcoholism
2001
An Outbreak of Travel-Associated Legionnaires Disease and Pontiac Fever: The Need for Enhanced Surveillance of Travel-Associated Legionellosis in the United States
Benin A, Benson R, Arnold K, Fiore A, Cook P, Williams L, Fields B, Besser R. An Outbreak of Travel-Associated Legionnaires Disease and Pontiac Fever: The Need for Enhanced Surveillance of Travel-Associated Legionellosis in the United States. The Journal Of Infectious Diseases 2001, 185: 237-243. PMID: 11807698, DOI: 10.1086/338060.Peer-Reviewed Original ResearchConceptsLegionnaires' diseasePontiac feverOutbreaks of LDTravel Associated Legionnaires' DiseaseImmunoglobulin M antibodiesLegionella pneumophila serogroup 6Fragment length polymorphism typingIgM seropositivityCohort studyM antibodiesIndex patientsPF casesEnhanced surveillanceSPA exposureOutbreak investigationSerogroup 6DiseaseWhirlpool spaFeverPolymorphism typingOutbreakNew laboratory techniquesLegionellosisSurveillanceEnvironmental investigations